Filing Details

Accession Number:
0001490978-24-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-13 19:35:18
Reporting Period:
2024-02-12
Accepted Time:
2024-02-13 19:35:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1490978 Schrodinger Inc. SDGR Pharmaceutical Preparations (2834) 954284541
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797730 Patrick Kenneth Lorton C/O Schrodinger, Inc.,
1540 Broadway, 24Th Floor
New York NY 10036
Evp, Cto & Coo, Software No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-12 901 $28.29 36,487 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 9, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.
  2. Includes 6,128 unvested RSUs.